DV
Dividend Vision

ABCL — AbCellera Biologics Inc.

AbCellera Biologics Inc. (ABCL)

Total return is -80.7% over the past 5.7 years, 209.9 points behind SPY at 129.2%. Its deepest 1-year drawdown was 54.9%.

AbCellera Biologics Inc. is a healthcare equity stock that operates in the biologics and biotechnology sector. The company does not currently pay distributions, making it a non-dividend-paying equity holding with no yield profile. This security appeals primarily to growth-oriented investors seeking exposure to the healthcare and biotechnology space rather than those prioritizing current income.

ABCL key facts

Asset type
Stock
Asset class
Equity
Inception date
12/11/2020
Distribution frequency
None
Last close
$11.38
Market cap
$3,489,238,528
Average volume
12332100.0
Beta
1.191
Payout ratio
0.0
Forward P/E
27.5482
EPS
$-0.54